Technical Analysis for MXCT - MaxCyte, Inc.

Grade Last Price % Change Price Change
F 7.23 -0.14% -0.01
MXCT closed down 6.82 percent on Tuesday, January 18, 2022, on 48 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical MXCT trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish -0.14%
Stochastic Buy Signal Bullish -0.14%
Lower Bollinger Band Walk Weakness -0.14%
New 52 Week Low Weakness -0.14%
Wide Bands Range Expansion -0.14%
Below Lower BB Weakness -0.14%
Down 3 Days in a Row Weakness -0.14%
Down 4 Days in a Row Weakness -0.14%
Down 5 Days in a Row Weakness -0.14%
Lower Bollinger Band Touch Weakness -0.14%
Older End-of-Day Signals for MXCT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below Previous Day's Low about 2 hours ago
Down 2 % about 2 hours ago
Down 1% about 2 hours ago
New 52 Week Low about 2 hours ago
Rose Above Lower Bollinger Band about 2 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

MaxCyte is a leading provider of cell-engineering platform technologies to advance innovative cell-based research, development and potential commercialization of next-generation cell therapies. The company's existing customer base ranges from large biopharmaceutical companies — including 20 of the top 25 pharmaceutical companies based on 2020 global revenue — to hundreds of biotechnology companies and academic translational centers. MaxCyte has granted 13 strategic platform licenses to commercial cell therapy developers that allow for more than 75 clinical programs. Founded in 1998, MaxCyte is headquartered in Gaithersburg, Maryland, US.
Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Pharmaceutical Industry Pharmacy Cell Therapy Genscript Biotech Synbio

Is MXCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.44
52 Week Low 7.16
Average Volume 847,229
200-Day Moving Average 0.00
50-Day Moving Average 10.25
20-Day Moving Average 9.39
10-Day Moving Average 8.51
Average True Range 0.67
ADX 20.17
+DI 12.47
-DI 31.81
Chandelier Exit (Long, 3 ATRs) 9.01
Chandelier Exit (Short, 3 ATRs) 9.16
Upper Bollinger Bands 11.54
Lower Bollinger Band 7.24
Percent B (%b) 0.0
BandWidth 45.82
MACD Line -0.73
MACD Signal Line -0.50
MACD Histogram -0.2305
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.95
Resistance 3 (R3) 8.00 7.81 7.83
Resistance 2 (R2) 7.81 7.63 7.79 7.79
Resistance 1 (R1) 7.53 7.52 7.44 7.48 7.75
Pivot Point 7.34 7.34 7.30 7.32 7.34
Support 1 (S1) 7.06 7.16 6.97 7.01 6.73
Support 2 (S2) 6.87 7.05 6.85 6.69
Support 3 (S3) 6.59 6.87 6.65
Support 4 (S4) 6.54